Johnson and Johnson's (J&J) Chief Finance Officer Joseph Wolk said on Tuesday that the American pharmaceutical giant expects around $400 million in tariff-related costs this year, mostly pertaining to China.In a conference call with analysts discussing the company's latest earning results, Chief...
As the earnings season heats up, all eyes are set on Tuesday when Netflix, one of the more noteworthy names this week, is due to announce its fourth-quarter results, with the streaming giant's revenue expected to land at $10.1 billion.Another big name reporting this week is Johnson & Johnson,...
Johnson & Johnson said on Thursday that its board decided to declare a cash dividend of $1.24 per share for the first quarter of this year.The dividend will be payable on March 4 to shareholders on record at the market close of February 18.J&J's shares rose 0.40% in premarket trading following the...
Johnson and Johnson (J&J) announced on Tuesday that sales in the first quarter of fiscal 2024 increased by 2.3% to $21.4 billion. The company's net income amounted to $5.3 billion for the three months reported.
Moreover, J&J's earnings per share (EPS) rose from a loss of $0.19 last year to a gain...
United States Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP) Bernie Sanders announced in a statement that CEOs from Johnson & Johnson and Merck & Co. Inc. will be joining Bristol Myers Squibb Co. CEO Chris Boerner at a hearing related to "outrageously...
Washington state Attorney General Bob Ferguson announced on Wednesday that Johnson & Johnson agreed to pay $149.5 million to settle the state's lawsuit, which alleged the company participated in "fueling the opioid epidemic." Under the settlement, $123.3 million of the total sum will be used to...
Johnson & Johnson reached a tentative agreement to pay roughly $700 million to resolve an investigation into the company's marketing of the talcum-based baby powder in the United States, Chief Financial Officer Joseph Wolk told The Wall Street Journal in an interview on Tuesday.
Wolk...
Johnson and Johnson (J&J) will be publishing its financial results for the fourth and final quarter of 2023 before the markets open in New York on Tuesday.
According to FactSet, the pharmaceutical company is expected to collect $21.02 billion in revenue in the fourth quarter, down from the...
The jam-packed earnings week is just about to commence, with Tesla Inc.'s results, which will come out on January 24, at the center of attention. The carmaker's revenue is seen rising somewhat on an annual basis, according to analysts. Other big names also joining the line-up are Johnson and...
Johnson and Johnson (J&J) announced on Tuesday that sales in the third quarter of fiscal 2023 increased by 6.8% to $21.4 billion. According to the company, for the three months reported, net income held steady at $4.3 billion.
Meanwhile, diluted Earnings per Share (EPS) rose by 4.3% to $1.69....
This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.
